Skip to main content
. 2023 Jul 22;15:118. doi: 10.1186/s13148-023-01535-4

Table 3.

Monitoring of NPTX2 methylation frequencies

Methylation monitoring n BMP3m NPTX2m SPARCm SFRP1m TFPI2m
To diagnosis 8 5 (62.5%) 7 (87.5%) 1 (12.5%) 1 (12.5%) 1 (12.5%)
After treatment 24 4 (16.67%) 16 (66.67%) 1 (4.17%) 3 (12.5%) 1 (4.17%)